Trial Details
Not recruitingBasic Information
| Clinical ID | c3328 |
|---|---|
| Identifier | NCT00658827 |
| Trial Title | Exposure to Remicade (Infliximab) During Pregnancy in Patients With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis and Psoriasis: a Review and Analysis of Birth Outcomes From the Swedish, Danish and Finnish Medical Birth Registers |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Inflammatory Bowel Disease |
| Interventions | Other: No intervention |
Participant Information
| Sponsor | Janssen Biotech, Inc. |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | FEMALE |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Observational |
|---|---|
| Phase | Not Available |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |